Freund M - Search Results

1

Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation.

Herzberg PY, Heussner P, Mumm FH, Horak M, Hilgendorf I, von Harsdorf S, Hemmati P, Rieger K, Greinix H, Freund M, Lee SJ, Holler E, Wolff D. Herzberg PY, et al. Among authors: freund m. Biol Blood Marrow Transplant. 2010 Dec;16(12):1707-17. doi: 10.1016/j.bbmt.2010.05.018. Epub 2010 Jun 9. Biol Blood Marrow Transplant. 2010. PMID: 20541028 Free article.

2

Validation of the grip test and human activity profile for evaluation of physical performance during the intermediate phase after allogeneic hematopoietic stem cell transplantation.

Kramer M, Heussner P, Herzberg PY, Andree H, Hilgendorf I, Leithaeuser M, Junghanss C, Freund M, Wolff D. Kramer M, et al. Among authors: freund m. Support Care Cancer. 2013 Apr;21(4):1121-9. doi: 10.1007/s00520-012-1634-1. Epub 2012 Nov 1. Support Care Cancer. 2013. PMID: 23111942

3

Sirolimus in combination with tacrolimus in allogeneic stem cell transplantation--timing and conditioning regimen may be crucial.

Wolff D, Andree H, Hilgendorf I, Casper J, Freund M, Junghanss C. Wolff D, et al. Among authors: freund m. Biol Blood Marrow Transplant. 2008 Aug;14(8):942-3. doi: 10.1016/j.bbmt.2008.05.004. Biol Blood Marrow Transplant. 2008. PMID: 18640579 Free article. No abstract available.

4

Vaccination of allogeneic haematopoietic stem cell transplant recipients: report from the international consensus conference on clinical practice in chronic GVHD.

Hilgendorf I, Freund M, Jilg W, Einsele H, Gea-Banacloche J, Greinix H, Halter J, Lawitschka A, Wolff D, Meisel R. Hilgendorf I, et al. Among authors: freund m. Vaccine. 2011 Apr 5;29(16):2825-33. doi: 10.1016/j.vaccine.2011.02.018. Epub 2011 Feb 20. Vaccine. 2011. PMID: 21345379

5

The lack of memory B cells including T cell independent IgM+ IgD+ memory B cells in chronic graft-versus host disease is associated with susceptibility to infection.

Hilgendorf I, Mueller-Hilke B, Kundt G, Holler E, Hoffmann P, Edinger M, Freund M, Wolff D. Hilgendorf I, et al. Among authors: freund m. Transpl Int. 2012 Jan;25(1):87-96. doi: 10.1111/j.1432-2277.2011.01388.x. Epub 2011 Nov 21. Transpl Int. 2012. PMID: 22098606 Free article.

6

Chronic graft versus host disease but not the intensity of conditioning has impact on survival after allogeneic hematopoietic stem cell transplantation for advanced hematological diseases.

Hilgendorf I, Wolff D, Nogai A, Kundt G, Hahn J, Holler E, Uharek L, Junghanss C, Leithäuser M, Thiel E, Freund M, Kahl C. Hilgendorf I, et al. Among authors: freund m. Onkologie. 2012;35(9):487-92. doi: 10.1159/000341835. Epub 2012 Aug 13. Onkologie. 2012. PMID: 23007145 Clinical Trial.

7

A prospective, randomized evaluation of the feasibility of exergaming on patients undergoing hematopoietic stem cell transplantation.

Schumacher H, Stüwe S, Kropp P, Diedrich D, Freitag S, Greger N, Junghanss C, Freund M, Hilgendorf I. Schumacher H, et al. Among authors: freund m. Bone Marrow Transplant. 2018 May;53(5):584-590. doi: 10.1038/s41409-017-0070-8. Epub 2018 Jan 15. Bone Marrow Transplant. 2018. PMID: 29335629 Clinical Trial.

8

Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation.

Casper J, Knauf W, Kiefer T, Wolff D, Steiner B, Hammer U, Wegener R, Kleine HD, Wilhelm S, Knopp A, Hartung G, Dölken G, Freund M. Casper J, et al. Among authors: freund m. Blood. 2004 Jan 15;103(2):725-31. doi: 10.1182/blood-2002-11-3615. Epub 2003 Aug 28. Blood. 2004. PMID: 12947008 Free article. Clinical Trial.

9

Neurological complications after intrathecal liposomal cytarabine application in patients after allogeneic haematopoietic stem cell transplantation.

Hilgendorf I, Wolff D, Junghanss C, Kahl C, Leithaeuser M, Steiner B, Casper J, Freund M. Hilgendorf I, et al. Among authors: freund m. Ann Hematol. 2008 Dec;87(12):1009-12. doi: 10.1007/s00277-008-0546-0. Epub 2008 Aug 13. Ann Hematol. 2008. PMID: 18704421

10

Allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies after dose-escalated treosulfan/fludarabine conditioning.

Casper J, Wolff D, Knauf W, Blau IW, Ruutu T, Volin L, Wandt H, Schäfer-Eckart K, Holowiecki J, Giebel S, Aschan J, Zander AR, Kröger N, Hilgendorf I, Baumgart J, Mylius HA, Pichlmeier U, Freund M. Casper J, et al. Among authors: freund m. J Clin Oncol. 2010 Jul 10;28(20):3344-51. doi: 10.1200/JCO.2009.23.3429. Epub 2010 May 24. J Clin Oncol. 2010. PMID: 20498405

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

943 results

Search Page

Filters